[{"Assets_0_Q1_USD":132248000.0,"CommonStockSharesOutstanding_0_Q1_shares":23392534.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-16662000.0,"NetIncomeLoss_1_Q1_USD":-14103000.0,"StockholdersEquity_0_Q1_USD":100825000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]